Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Direct sales in China

This article was originally published in The Rose Sheet

Executive Summary

Mary Kay and Amway both received direct-selling licenses in China this month. "The direct selling authorization will open a new chapter in the business development of Amway China," company states Dec. 5. Mary Kay China, in a Dec. 8 statement, is similarly optimistic: "We anticipate that our status as a direct-selling company will facilitate our long-term market development in what is our second-largest market." China banned direct selling in 1998 after a rash of pyramid schemes countrywide threatened the stability of its socio-economic infrastructure. Commitments made under China's 2001 accession to the World Trade Organization offered some flexibility, and implementation of the Anti-Pyramid Regulation and Direct Selling Regulation in late 2005 legalized direct selling among licensed firms, though multi-level compensation remains prohibited. Avon says it was first to secure direct-selling permission in March; to date, it has recruited approximately 300,000 licensed sales reps. All three companies have been operating within a retail sales format since China's elimination of "face-to-face" marketing (1"The Rose Sheet" April 19, 1999, p. 9)...

You may also be interested in...



Sales & Earnings In Brief

Avon: Company says its "turnaround continues to gain traction," as investments in advertising and field personnel contribute to 14% growth in beauty sales to $1.65 bil. for fiscal 2007 second quarter and a 9% increase in active representatives, according to July 31 release. Within its beauty segment, the firm recorded increased sales of fragrance (up 21%), personal care (up 19%), color cosmetics (up 16%) and skin care (up 4%). Given the success of its renewed promotional effort to date, Avon is upping its full-year advertising spend to $375 mil. - 50% more than that allocated for 2006; its earlier plan was to increase advertising investment levels by 35%, Chair and CEO Andrea Jung notes. Revenue in North America was flat for the quarter, the average size of an order declining versus the prior-year quarter "primarily due to last year's strong product innovation in the skin-care category," including the debut of firm's Anew Clinical Eye Lift. Double-digit gains were posted in Latin America, Central and Eastern Europe, and Western Europe, Middle East and Africa, as well as in China, where Avon continues to expand its direct-selling business (1"The Rose Sheet" Dec. 18, 2006, In Brief). Total Q2 revenue climbed 12% to $2.3 bil...

Do Your Homework Before Diving Into China’s Cosmetics Market, Expert Says

Companies with an eye toward China's cosmetics marketplace must realistically assess the scope of that opportunity available to them before committing any further resources, according to Merrill Weingrod, CEO of consulting firm China Strategies

Direct Sales Ban In China Could Be Lifted By 2003 Under WTO Accession Deal

The U.S.-China World Trade Organization accession agreements include abolishment of the direct-selling ban in China within three years, according to the Market Access Commitments of the Government of China on Goods, Services and Agriculture treaty between the two countries. The April 10 agreement is subject to approval from Congress and the President.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel